Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002238638 | SCV002511808 | likely pathogenic | 3-M syndrome | 2022-04-08 | criteria provided, single submitter | clinical testing | Variant summary: CUL7 c.649_654delAGCCGC (p.Ser217_Arg218del) results in an in-frame deletion that is predicted to remove two highly conserved amino acids from the encoded protein. The variant was absent in 251496 control chromosomes. c.649_654delAGCCGC has been reported in the literature at least one large consanguineous family in the homozygous state in affected individuals with characteristic radiologic findings of Three M Syndrome 1 (eg. Akawi_2011). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. |